Low melatonin production in infants with a life‐threatening event

Abstract

This study compares the urinary excretion of the main melatonin metabolite, 6‐sulfatoxymelatonin (6SMT), in infants who have and have not experienced a life‐threatening event (ALTE). 6SMT was assessed in the following groups of infants: 15 infants with ALTE for whom home monitoring had been recommended, 15 infants who had had an abrupt cyanotic apneic event but did not require mouth‐to‐mouth resuscitation, 15 siblings of those who had died from sudden infant death syndrome (SIDS), and 35 age‐matched healthy comparison infants. All 80 infants were between 48 and 58 weeks of postconceptional age. On a double‐blind basis, the total amount of 6SMT excreted over 24 hours and the diurnal rhythm in the rate of 6SMT excretion were assessed using urine samples taken from disposable diapers (nappies). The mean daily excretion of 6SMT was significantly lower in the ALTE (1588ng/24 hour) than in the comparison infants (3961 ng/24 hour). No such difference was found between the infants with a cyanotic apneic event (3268 ng/24 hour) and the SIDS siblings (2962 ng/24 hour). The diurnal 6SMT rhythms in the ALTE infants were characterized by lower 24‐hour mean and amplitude values, whereas the time of peak and nadir excretion rates (07:15 to 08:45 hours and 14:45 to 16:15 hours respectively) was similar in all four infant groups. Follow‐up of the ALTE infants, performed 6 to 8 weeks later (59 to 66 weeks of postconceptional age), revealed that 6SMT excretion increased in all of them, suggesting a delayed ontogeny rather than permanent deficiency of melatonin production in ALTE.